Condition: Hypertension · Bradycardia · Sponsor: BackBeat Medical Inc
After meeting all inclusion/exclusion criteria, subjects on standard pacing with the Moderato® or Moderato Plus Implantable Pulse Generator (IPG) will be subjected to two set-up sessions for the CNT algorithm: at week 4 and at week 6 post implant. At the end of these visits, subjects will undergo a 24 ambulatory blood pressure recording after which CNT will be automatically turned OFF and standard pacing will resume. The ambulatory data will provide the basis for a lasting CNT programming by week 8. Follow up visits will be scheduled after 3, 6, and 12 months.
This description comes directly from the study's public registry record.
Linda Korthout · +41783482383 · lkorthout@orchestrabiomed.com
Always discuss trial participation with your own doctor first.
| Nemocnice Na Homolce (Na Homolce Hospital) | Prague, Czechia | Not Yet Recruiting |
| Semmelweis University Heart and Vascular Center | Budapest, Hungary | Recruiting |
| Jagiellonian University Hospital | Krakow, Poland | Not Yet Recruiting |
| Uniwersytecki Szpital Kliniczny w Poznaniu | Poznan, Poland | Not Yet Recruiting |
| Samodzielny Pub. Szpital Kliniczny nr 2 PUM | Szczecin, Poland | Not Yet Recruiting |
| Publiczny Centralny Szpital | Warsaw, Poland | Not Yet Recruiting |
| Silesian Center for Heart Diseases | Zabrze, Poland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05719454